Jennifer L. Faulkner

Research Associate III

UAMS primary UA Little Rock

Also affiliated: The University of Texas at San Antonio Health Science Center (2001–2005); Murphy Oil Corporation (United States) (2005); Winthrop Rockefeller Foundation (2025–2026); South Texas Veterans Health Care System (2001–2005)

Postdoc Researcher

8 h-index 15 pubs 358 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Jennifer L. Faulkner's research has focused on therapeutic vaccines and their application in cancer treatment. She has investigated peptide-based human papillomavirus therapeutic vaccines, such as PepCan, for the treatment of cervical intraepithelial neoplasia (CIN2/3). Her work also includes evaluating the efficacy of these vaccines in reducing head and neck cancer recurrence, as demonstrated in a Phase I/II clinical trial. Additionally, Faulkner has contributed to characterizing immune correlates of tumor response in breast cancer patients who received a P10s-PADRE vaccine.

Her research has led to publications in peer-reviewed journals, and she has a collaborative network with researchers at the University of Arkansas for Medical Sciences, including David W. Ussery, Yong‐Chen Lu, Jasmine Crane, and Nadia Darwish, with whom she has co-authored multiple publications. Faulkner's scholarly output is reflected in an h-index of 8 and 357 total citations across 15 publications.

Metrics

h-index: 8
Publications: 15
Citations: 358

Selected Publications

A pilot study utilizing hypothermia to reduce chemotherapy-induced peripheral neuropathy (2026)

Gynecologic Oncology DOI OpenAlex
A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence (2026)

medRxiv DOI OpenAlex
A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i> (2025)

medRxiv 3 citations DOI OpenAlex
Abstract 3860: Characterizing peripheral immune correlates of tumor response in breast cancer patients immunized with the P10s-PADRE vaccine (2024)

Cancer Research DOI OpenAlex
A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). (2023)

Journal of Clinical Oncology 2 citations DOI OpenAlex
Can Automated Alerts in the Electronic Health Record Encourage Referrals for Genetic Counseling and Testing Among Patients at High Risk for Hereditary Cancer Syndromes? (2022)

JCO Oncology Practice 10 citations DOI OpenAlex
Evaluating the Use of Mobile Health Technology in Older Adults With Heart Failure: Mixed-Methods Study (2018)

JMIR Aging 68 citations DOI OpenAlex
Delay discounting of hypothetical monetary rewards with decoys (2015)

Behavioural Processes 9 citations DOI OpenAlex